Colgate-Palmolive Company $CL Holdings Raised by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 144.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 985,758 shares of the company’s stock after buying an additional 582,523 shares during the period. TD Waterhouse Canada Inc. owned 0.12% of Colgate-Palmolive worth $84,105,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. Cooper Financial Group lifted its position in shares of Colgate-Palmolive by 4.0% in the second quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock valued at $270,000 after acquiring an additional 114 shares in the last quarter. Gould Capital LLC increased its position in Colgate-Palmolive by 38.7% during the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after purchasing an additional 115 shares in the last quarter. Redhawk Wealth Advisors Inc. increased its position in Colgate-Palmolive by 2.8% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock worth $397,000 after purchasing an additional 118 shares in the last quarter. SVB Wealth LLC raised its stake in Colgate-Palmolive by 1.4% in the 2nd quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock valued at $804,000 after purchasing an additional 119 shares during the last quarter. Finally, ANB Bank raised its stake in Colgate-Palmolive by 1.7% in the 1st quarter. ANB Bank now owns 7,200 shares of the company’s stock valued at $614,000 after purchasing an additional 120 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.5%

Colgate-Palmolive stock traded up $1.35 during trading on Friday, hitting $94.02. The company’s stock had a trading volume of 5,775,087 shares, compared to its average volume of 5,409,072. The stock’s fifty day moving average is $89.05 and its 200 day moving average is $89.02. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The stock has a market capitalization of $74.95 billion, a price-to-earnings ratio of 37.31, a P/E/G ratio of 4.43 and a beta of 0.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.04. The firm had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. The firm’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period last year, the company earned $0.92 EPS. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio is presently 84.13%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday, August 13th. Evercore lifted their price target on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a research report on Monday, August 3rd. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating for the company in a research report on Monday, October 5th. Finally, Morgan Stanley reissued an “overweight” rating and set a $104.00 price objective (up from $100.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Thirteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $97.95.

Insider Buying and Selling

In related news, CEO Noel Wallace sold 161,021 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total value of $14,801,050.32. Following the sale, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John Cahill sold 4,170 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 175,191 shares of company stock valued at $16,110,903. Insiders own 0.43% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.